F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comTarsons Products Ltd is a leading life sciences company in India, primarily engaged in manufacturing laboratory plasticware used in research, diagnostics, and biotech sectors. With a focus on innovation, product quality, and global expansion, Tarsons has established itself as a key player in the laboratory consumables market. In this article, we’ll explore the Tarsons Products Ltd share price target from 2025 to 2030, along with detailed financial data, business insights, and investment advice.
| Detail | Value |
|---|---|
| Open | ₹292.30 |
| Previous Close | ₹290.25 |
| Day’s High | ₹292.45 |
| Day’s Low | ₹288.15 |
| VWAP | ₹289.79 |
| Volume | 58,165 |
| Value (Lacs) | ₹168.59 |
| Beta (Volatility) | 0.86 |
| Market Capitalization (Rs. Cr.) | ₹1,542 |
| 52-Week High | ₹464.30 |
| 52-Week Low | ₹280.00 |
| Upper Circuit Limit (UC) | ₹348.30 |
| Lower Circuit Limit (LC) | ₹232.20 |
| Face Value | ₹2 |
| All-Time High | ₹924.90 |
| All-Time Low | ₹280.00 |
The company’s current trading range shows that the stock is near its 52-week low, presenting potential value for long-term investors if the fundamentals remain strong.
Founded in 1983, Tarsons Products Ltd is one of India’s most trusted brands in laboratory consumables. The company designs and manufactures a wide range of reusable and disposable plastic lab products used in molecular biology, cell culture, and microbiology.
Leading manufacturer of laboratory plasticware in India
Exports to over 40 countries
Strong presence in life sciences, pharmaceuticals, and biotech sectors
Focused on automation and R&D-driven innovation
Growing distribution network and brand recognition
With increasing demand for life science research tools and healthcare advancements, Tarsons is strategically positioned to benefit from the rising need for laboratory infrastructure globally.
| Investor Type | Holding (%) |
|---|---|
| Promoters | 47.31% |
| Retail & Others | 46.78% |
| Foreign Institutions | 5.82% |
| Other Domestic Institutions | 0.08% |
This shareholding pattern reflects a healthy mix of promoter confidence and retail participation, which typically supports long-term stock stability.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2025 | 295 | 310 |
| 2026 | 320 | 340 |
| 2027 | 350 | 380 |
| 2028 | 385 | 420 |
| 2029 | 430 | 470 |
| 2030 | 480 | 525 |
These projections consider Tarsons’ revenue growth potential, market expansion, R&D investment, and overall sector demand in biotechnology and pharmaceuticals.
By 2025, Tarsons’ stock may remain range-bound as it consolidates after previous corrections. The company’s focus on exports and cost optimization could support gradual growth.
Why?
Increasing demand from diagnostics and research sectors
Stable margins despite raw material cost fluctuations
Moderate Beta (0.86) indicates lower volatility
Investment Advice: Long-term investors can start accumulating shares at current levels for steady returns.
In 2026, Tarsons is expected to benefit from its diversified client base and consistent export revenue growth.
Why?
Expansion in overseas markets
Introduction of new product lines in lab consumables
Improvement in operating profit margin (OPM)
Investment Advice: Hold for medium-term growth; expect positive momentum if quarterly results remain strong.
By 2027, R&D investment and brand expansion could drive earnings growth, with Tarsons establishing a stronger foothold in international markets.
Why?
Product innovation in molecular biology consumables
Higher contribution from export revenue
Growing demand for biotech research equipment
Investment Advice: A good year to reinvest dividends; maintain SIPs for compounding gains.
In 2028, Tarsons may cross the ₹400 mark, supported by strong sector growth and better cost efficiency.
Why?
Expansion in manufacturing capacity
Strong cash flows and low debt levels
Potential government initiatives for biotech sector support
Investment Advice: Suitable for long-term investors looking for stability and capital appreciation.
Tarsons could continue its upward trend due to consistent growth in revenue and profit margins.
Why?
Rising exports and global collaborations
Improved supply chain and logistics
Enhanced brand visibility among research institutions
Investment Advice: Hold for long-term gains; avoid short-term trading volatility.
By 2030, Tarsons may see significant value creation as demand for life science consumables surges globally.
Why?
Sustained growth in healthcare and diagnostics sectors
Strong promoter backing (47.31%)
Consistent innovation and export diversification
Investment Advice: Excellent long-term investment for investors seeking exposure to India’s fast-growing life sciences sector.
Yes. Tarsons Products Ltd offers a promising long-term opportunity due to its strong fundamentals, innovation-driven growth, and leadership in laboratory consumables manufacturing.
High promoter holding shows management confidence
Expanding export base and R&D innovation
Lower volatility (Beta 0.86) compared to market average
Near 52-week low, offering potential upside
Fluctuation in polymer/raw material costs
Dependence on research and pharma demand cycles
Global economic slowdown impacting exports
Always consult a certified financial advisor before investing.
Tarsons Products Ltd is fundamentally strong with a growing footprint in the life sciences and laboratory consumables market. The company’s long-term outlook remains positive, supported by strong promoter confidence and innovation in product design.
Currently trading around ₹290–₹292, Tarsons has potential to touch ₹525 by 2030 if it maintains consistent earnings growth and expands globally. Investors looking for a stable, growth-oriented mid-cap stock can consider Tarsons for long-term portfolio diversification.
1. What is the current share price of Tarsons Products Ltd?
The current share price is around ₹292 (as of October 27, 2025).
2. What is Tarsons Products Ltd’s 52-week high and low?
The 52-week high is ₹464.30, and the 52-week low is ₹280.00.
3. What is the share price target for Tarsons Products Ltd in 2025?
The estimated target for 2025 is between ₹295 and ₹310.
4. Is Tarsons Products Ltd a good buy now?
Yes, the stock is near its 52-week low and may offer good long-term returns.
5. What is Tarsons Products Ltd’s market capitalization?
The company’s market cap is ₹1,542 crore.
6. What is the promoter holding in Tarsons Products Ltd?
Promoters hold 47.31% of the total shares.
7. What is the long-term target for Tarsons Products Ltd?
By 2030, the stock could reach between ₹480 and ₹525, depending on market performance.
8. Does Tarsons Products Ltd have foreign investors?
Yes, foreign institutions hold around 5.82% of the shares.
9. What sector does Tarsons Products Ltd belong to?
It operates in the life sciences, biotechnology, and laboratory consumables sector.
10. Should I invest in Tarsons Products Ltd for 5 years?
Yes, long-term investment could yield significant returns due to sectoral growth and stable fundamentals.
Register & Login